Merck & Co Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (111)

Latest Posts

About This Stock More About This Stock
Pharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod
Article By: Arpita Dutt
Friday, November 10, 2017 3:13 PM EST
Earnings remained in focus this week with companies like AstraZeneca reporting third-quarter results. Meanwhile, companies like Roche and Merck & Co., Inc. were in the news due to regulatory updates.
In this article: AZN, GSK, MRK Also: JNJ, LLY, SNY, RHHBY
Read
Merck: A Slow And Steady Dividend Grower, But Do Better Alternatives Exist?
Article By: Simply Safe Dividends
Tuesday, October 31, 2017 4:04 AM EST
While the pharmaceutical industry as a whole may be recession resistant, successful long-term dividend growth investing is far harder to achieve at the company level.
In this article: MRK Also: JNJ, PFE
Read
Merck (MRK) Q3 Earnings Top, Sales Lag, Keytruda Stays Strong
Article By: Zacks Investment Research
Friday, October 27, 2017 3:00 PM EST
Merck & Co., Inc. reported third-quarter 2017 adjusted earnings of $1.11 per share, which beat the Zacks Consensus Estimate of $1.03 by 7.8%. Earnings rose 3.7% year over year.
In this article: MRK Also: AZN, JNJ, LLY, SNY
Read
Why Are These 6 Dow Stocks Fairly Valued? - Part 4
Video By: Chuck Carnevale
Thursday, October 19, 2017 10:04 AM EST
I will present a quick overview of six Dow constituents based primarily on price relative to earnings and cash flow.
In this video: AXP, GE, MRK, PFE, TRV, JPM
Watch
Merck Upgraded To Buy From Neutral At Citi
Article By: The Fly
Wednesday, October 18, 2017 6:53 AM EST
The analyst revised his initial PDx market estimates of $35bn to at least $50bn and increased his 2025 Keytruda forecasts from $9B to$15B.
In this article: MRK Also: LLY, RHHBY
Read

PARTNER HEADLINES

Latest Tweets for $MRK

No tweets yet!

$MRK

OncoSec Raising Its Profile In Fight Against Cancer
Harry Goldstein 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer
Alexis Renault 9/6/2017 4:08:15 PM

Thanks for this info, Terry Chrisomalis. Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 3 of 3 comments